Given the high biological heterogeneity of PCa [36], the search for potential markers was carried out within the TMPRSS2–ERG molecular sub-type, which is characterized by the highest occurrence (46% of all cases of PCa) [1]. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.